SCHOTT Pharma AG & Co. KGaA

€21.75As of Sun 8 Nov 2026, 12:00 UTC
XETRA:1SXPHealthcare
Country Germany
PE (Fwd) •••
TSR 3Y CAGR (10.70%)
Div yield 0.83%
ROE 14.67%
Medical Instruments & Supplies
Beta (5Y) 0.86
PE TTM 24.17
TSR TTM 13.41%
Mkt cap €3.276B
ROIC 10.46%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€22
2.03%
(68.25%)
Hold 3|2|1|11|7
1Q26
2Q26
3Q26
4Q26
Earnings per share€
0.39
0.43
0.46
0.44
17.61%
18.53%
20.94%
19.52%
Revenue€M
184.7
180.5
176.8
180.3
12.47%
6.19%
5.37%
2.30%
Peers (US$3.678B)
Cap (US$)
PE
4.120B
17.23x
3.436B
25.07x
3.366B
23.14x
3.706B
23.43x
Capital
TTM
5Y
10Y
Leveragex
1.683
0.029
0.028
EBIT/Intx
3.051
0.134
0.124
Own earn%
(37.24)
111.23
99.77
Sh yield%
40.27
56.02
55.34
Owners
Insiders/Inst%
10.19
59.61
Short interest%
2.18
SBC / revenue%
4.08
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
12–16
$1 testx
0.1
Incr. ROIC%
10